Evidence map›Paper›PMID 41185550›Full record

ArticlePediatric dermatology

TNF Inhibitor Therapy in Corticosteroid-Resistant or -Dependent Pediatric Neutrophilic Dermatosis.

Laure Chêne, Thomas Hubiche, Jean-Marie De Guillebon, Maella Severino-Freire, Emmanuelle Bourrat, Sébastien Barbarot, Alice Phan, Christine Chiaverini

Abstract readCase Reports
In one paragraph

Article in Pediatric dermatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Laure ChêneService de Dermatologie, CHU Nice, Nice, France.
Thomas HubicheService de Dermatologie, CHU Nice, Nice, France.
Jean-Marie De GuillebonService de Néphrologie, Rhumatologie pédiatrique, Hôpitaux pédiatriques de Nice CHU-Lenval, Nice, France.
Maella Severino-FreireService de Dermatologie CHU Toulouse, Toulouse, France.
Emmanuelle BourratService de Dermatologie, Assistance Publique-Hôpitaux de Paris, Université de Paris, Paris, France.
Sébastien BarbarotService de Dermatologie, CHU de Nantes, Nantes, France.
Alice PhanService de Pédiatrie, Hôpital Mère Enfant, Bron, France.
Christine ChiaveriniService de Dermatologie, CHU Nice, Nice, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neutrophilic dermatoses are rare in children. Systemic corticosteroids are the first-line treatment, but guidelines for second-line therapies are lacking. We report five cases of children with systemic steroid-resistant/dependent neutrophilic dermatoses, successfully treated with tumor necrosis factor inhibitors.

Indexed as

Sweet SyndromeTumor Necrosis Factor InhibitorsAdolescentAdrenal Cortex HormonesChildChild, PreschoolDrug ResistanceFemaleHumansMaleNeutrophilsAdrenal Cortex HormonesTumor Necrosis Factor Inhibitorschildpyoderma gangrenosumsweet syndrome

Identifiers

PMID41185550
PMCPMC13051018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.